HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.

AbstractPURPOSE:
To evaluate and compare the efficacy of medium-dose-rate (MDR) and low-dose-rate (LDR) intracavitary brachytherapy (ICBT) for uterine cervical cancer.
METHODS AND MATERIALS:
We evaluated 419 patients with squamous cell carcinoma of the cervix who were treated by radical radiotherapy with curative intent at Tokyo Women's Medical University from 1969 to 1999. LDR was used from 1969 to 1986, and MDR has been used since July 1987. When compared with LDR, fraction dose was decreased and fraction size was increased (1 or 2 fractions) for MDR to make the total dose of MDR equal to that of LDR. In general, the patients received a total dose of 60 to 70 Gy at Point A with external beam radiotherapy combined with brachytherapy according to the International Federation of Gynecology and Obstetrics stage. In the LDR group, 32 patients had Stage I disease, 81 had Stage II, 182 had Stage III, and 29 had Stage IVA; in the MDR group, 9 patients had Stage I disease, 19 had Stage II, 55 had Stage III, and 12 had Stage IVA.
RESULTS:
The 5-year overall survival rates for Stages I, II, III, and IVA in the LDR group were 78%, 72%, 55%, and 34%, respectively. In the MDR group, the 5-year overall survival rates were 100%, 68%, 52%, and 42%, respectively. No significant statistical differences were seen between the two groups. The actuarial rates of late complications Grade 2 or greater at 5 years for the rectum, bladder, and small intestine in the LDR group were 11.1%, 5.8%, and 2.0%, respectively. The rates for the MDR group were 11.7%, 4.2%, and 2.6%, respectively, all of which were without statistical differences.
CONCLUSION:
These data suggest that MDR ICBT is effective, useful, and equally as good as LDR ICBT in daytime (about 5 hours) treatments of patients with cervical cancer.
AuthorsYuko Kaneyasu, Midori Kita, Tomohiko Okawa, Katsuya Maebayashi, Mari Kohno, Tatsuo Sonoda, Hisae Hirabayashi, Yasushi Nagata, Norio Mitsuhashi
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 84 Issue 1 Pg. 137-45 (Sep 01 2012) ISSN: 1879-355X [Electronic] United States
PMID22285665 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Hemoglobin A
Topics
  • Adult
  • Aged
  • Brachytherapy (adverse effects, methods, mortality)
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy)
  • Female
  • Hemoglobin A (analysis)
  • Humans
  • Intestine, Small (radiation effects)
  • Middle Aged
  • Organs at Risk (radiation effects)
  • Radiation Injuries (pathology)
  • Radiotherapy Dosage
  • Rectum (radiation effects)
  • Survival Rate
  • Treatment Outcome
  • Urinary Bladder (radiation effects)
  • Uterine Cervical Neoplasms (blood, mortality, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: